<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30429254</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-660X</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of clinical microbiology</Title><ISOAbbreviation>J Clin Microbiol</ISOAbbreviation></Journal><ArticleTitle>Combination of Nonstructural Protein 1-Based Enzyme-Linked Immunosorbent Assays Can Detect and Distinguish Various Dengue Virus and Zika Virus Infections.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e01464-18</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JCM.01464-18</ELocationID><Abstract><AbstractText>The recent outbreaks of Zika virus (ZIKV) and associated birth defects in regions of dengue virus (DENV) endemicity emphasize the need for sensitive and specific serodiagnostic tests. We reported previously that enzyme-linked immunosorbent assays (ELISAs) based on the nonstructural protein 1 (NS1) of DENV serotype 1 (DENV1) and ZIKV can distinguish primary DENV1, secondary DENV, and ZIKV infections. Whether ELISAs based on NS1 proteins of other DENV serotypes can discriminate various DENV and ZIKV infections remains unknown. We herein developed DENV2, DENV3, and DENV4 NS1 IgG ELISAs to test convalescent- and postconvalescent-phase samples from reverse transcription-PCR-confirmed cases, including 25 primary DENV1, 24 primary DENV2, 10 primary DENV3, 67 secondary DENV, 36 primary West Nile virus, 38 primary ZIKV, and 35 ZIKV with previous DENV infections as well as 55 flavivirus-naive samples. Each ELISA detected primary DENV infection with a sensitivity of 100% for the same serotype and 23.8% to 100% for different serotypes. IgG ELISA using a mixture of DENV1-4 NS1 proteins detected different primary and secondary DENV infections with a sensitivity of 95.6% and specificity of 89.5%. The ZIKV NS1 IgG ELISA detected ZIKV infection with a sensitivity of 100% and specificity of 82.9%. On the basis of the relative optical density ratio, the combination of DENV1-4 and ZIKV NS1 IgG ELISAs distinguished ZIKV with previous DENV and secondary DENV infections with a sensitivity of 91.7% to 94.1% and specificity of 87.0% to 95.0%. These findings have important applications to serodiagnosis, serosurveillance, and monitoring of both DENV and ZIKV infections in regions of endemicity.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 American Society for Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tyson</LastName><ForeName>Jasmine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Wen-Yang</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Jih-Jin</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Tropical Medicine Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brites</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>LAPI-Laborat&#xf3;rio de Pesquisa em Infectologia School of Medicine, Federal University of Bahia, Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe4;ssg&#xe5;rd</LastName><ForeName>Ludvig</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha Youn</LastName><ForeName>Han</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedroso</LastName><ForeName>Celia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>LAPI-Laborat&#xf3;rio de Pesquisa em Infectologia School of Medicine, Federal University of Bahia, Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drexler</LastName><ForeName>Jan Felix</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt-Universit&#xe4;t zu Berlin, and Berlin Institute of Health, Institute of Virology, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Infection Research, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stramer</LastName><ForeName>Susan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>American Red Cross Scientific Support Office, Gaithersburg, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balmaseda</LastName><ForeName>Angel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Virology Laboratory, National Center for Diagnosis and Reference, Ministry of Health, Managua, Nicaragua.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei-Kung</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA wangwk@hawaii.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AI135292</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 GM114737</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AI106695</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 AI065359</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI110769</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI118610</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI099631</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Microbiol</MedlineTA><NlmUniqueID>7505564</NlmUniqueID><ISSNLinking>0095-1137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012698" MajorTopicYN="N">Serologic Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071244" MajorTopicYN="N">Zika Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071243" MajorTopicYN="N">Zika Virus Infection</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Zika virus</Keyword><Keyword MajorTopicYN="N">dengue virus</Keyword><Keyword MajorTopicYN="N">nonstructural protein 1</Keyword><Keyword MajorTopicYN="N">serodiagnosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30429254</ArticleId><ArticleId IdType="pmc">PMC6355536</ArticleId><ArticleId IdType="doi">10.1128/JCM.01464-18</ArticleId><ArticleId IdType="pii">JCM.01464-18</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Petersen LR, Jamieson DJ, Powers AM, Honein MA. 2016. Zika virus. N Engl J Med 374:1552&#x2013;1563. doi:10.1056/NEJMra1602113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1602113</ArticleId><ArticleId IdType="pubmed">27028561</ArticleId></ArticleIdList></Reference><Reference><Citation>Lessler J, Chaisson LH, Kucirka LM, Bi Q, Grantz K, Salje H, Carcelen AC, Ott CT, Sheffield JS, Ferguson NM, Cummings DA, Metcalf CJ, Rodriguez-Barraquer I. 2016. Assessing the global threat from Zika virus. Science 353:aaf8160. doi:10.1126/science.aaf8160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf8160</ArticleId><ArticleId IdType="pmc">PMC5467639</ArticleId><ArticleId IdType="pubmed">27417495</ArticleId></ArticleIdList></Reference><Reference><Citation>Krauer F, Riesen M, Reveiz L, Oladapo OT, Mart&#xed;nez-Vega R, Porgo TV, Haefliger A, Broutet NJ, Low N, WHO Zika Causality Working Group. 2017. Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barr&#xe9; syndrome: systematic review. PLoS Med 14:e1002203. doi:10.1371/journal.pmed.1002203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002203</ArticleId><ArticleId IdType="pmc">PMC5207634</ArticleId><ArticleId IdType="pubmed">28045901</ArticleId></ArticleIdList></Reference><Reference><Citation>Baud D, Gubler DJ, Schaub B, Lanteri MC, Musso D. 2017. An update on Zika virus infection. Lancet 390:2099&#x2013;2109. doi:10.1016/S0140-6736(17)31450-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31450-2</ArticleId><ArticleId IdType="pubmed">28647173</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. 2017.  Guidance for U.S. laboratories testing for Zika virus infection. CDC, Atlanta, GA. http://www.cdc.gov/zika/laboratories/lab-guidance.html.</Citation></Reference><Reference><Citation>Rabe IB, Staples JE, Villanueva J, Hummel KB, Johnson JA, Rose L, Hills S, Wasley A, Fischer M, Powers AM. 2016. Interim guidance for interpretation of Zika virus antibody test results. MMWR Morb Mortal Wkly Rep 65:543&#x2013;546. doi:10.15585/mmwr.mm6521e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6521e1</ArticleId><ArticleId IdType="pubmed">27254248</ArticleId></ArticleIdList></Reference><Reference><Citation>Paz-Bailey G, Rosenberg ES, Doyle K, Munoz-Jordan J, Santiago GA, Klein L, Perez-Padilla J, Medina FA, Waterman SH, Gubern CG, Alvarado LI, Sharp TM. 2018. Persistence of Zika virus in body fluids - final report. N Engl J Med 379:1234&#x2013;1243. doi:10.1056/NEJMoa1613108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1613108</ArticleId><ArticleId IdType="pmc">PMC5831142</ArticleId><ArticleId IdType="pubmed">28195756</ArticleId></ArticleIdList></Reference><Reference><Citation>Foy BD, Kobylinski KC, Chilson Foy JL, Blitvich BJ, Travassos da Rosa A, Haddow AD, Lanciotti RS, Tesh RB. 2011. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis 17:880&#x2013;882. doi:10.3201/eid1705.101939.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1705.101939</ArticleId><ArticleId IdType="pmc">PMC3321795</ArticleId><ArticleId IdType="pubmed">21529401</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks RB, Carlos MP, Myers RA, White MG, Bobo-Lenoci T, Aplan D, Blythe D, Feldman KA. 2016. Likely sexual transmission of Zika virus from a man with no symptoms of infection - Maryland, 2016. MMWR Morb Mortal Wkly Rep 65:915&#x2013;916. doi:10.15585/mmwr.mm6534e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6534e2</ArticleId><ArticleId IdType="pubmed">27585037</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson TC, Diamond MS. 2013. Flaviviruses, p 747&#x2013;794. In Knipe DM, Howley PM (ed), Fields virology, 6th ed Lippincott William &amp; Wilkins, Philadelphia, PA.</Citation></Reference><Reference><Citation>Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT. 2000. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 38:1823&#x2013;1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC86599</ArticleId><ArticleId IdType="pubmed">10790107</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson AJ, Martin DA, Karabatsos N, Roehrig JT. 2000. Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol 38:1827&#x2013;1831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC86600</ArticleId><ArticleId IdType="pubmed">10790108</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C-Y, Tsai W-Y, Lin S-R, Kao C-L, Hu H-P, King C-C, Wu H-C, Chang G-J, Wang W-K. 2008. Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol 82:6631&#x2013;6643. doi:10.1128/JVI.00316-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00316-08</ArticleId><ArticleId IdType="pmc">PMC2447043</ArticleId><ArticleId IdType="pubmed">18448542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, Stanfield SM, Duffy MR. 2008. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 14:1232&#x2013;1239. doi:10.3201/eid1408.080287.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1408.080287</ArticleId><ArticleId IdType="pmc">PMC2600394</ArticleId><ArticleId IdType="pubmed">18680646</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BW, Kosoy O, Martin DA, Noga AJ, Russell BJ, Johnson AA, Petersen LR. 2005. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. Vector Borne Zoonotic Dis 5:137&#x2013;145. doi:10.1089/vbz.2005.5.137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vbz.2005.5.137</ArticleId><ArticleId IdType="pubmed">16011430</ArticleId></ArticleIdList></Reference><Reference><Citation>van Meer MPA, M&#xf6;gling R, Klaasse J, Chandler FD, Pas SD, van der Eijk AA, Koopmans MPG, Reusken CBEM, GeurtsvanKessel CH. 2017. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence. J Clin Virol 92:25&#x2013;31. doi:10.1016/j.jcv.2017.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2017.05.001</ArticleId><ArticleId IdType="pubmed">28505571</ArticleId></ArticleIdList></Reference><Reference><Citation>Felix AC, Souza NCS, Figueiredo WM, Costa AA, Inenami M, da Silva RMG, Levi JE, Pannuti CS, Romano CM. 2017. Cross reactivity of commercial anti-dengue immunoassays in patients with acute Zika virus infection. J Med Virol 89:1477&#x2013;1479. doi:10.1002/jmv.24789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24789</ArticleId><ArticleId IdType="pubmed">28229481</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G, Duangchinda T, Sakuntabhai A, Cao-Lormeau VM, Malasit P, Rey FA, Mongkolsapaya J, Screaton GR. 2016. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus. Nat Immunol 17:1102&#x2013;1108. doi:10.1038/ni.3515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3515</ArticleId><ArticleId IdType="pmc">PMC4994874</ArticleId><ArticleId IdType="pubmed">27339099</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyamvada L, Quicke KM, Hudson WH, Onlamoon N, Sewatanon J, Edupuganti S, Pattanapanyasat K, Chokephaibulkit K, Mulligan MJ, Wilson PC, Ahmed R, Suthar MS, Wrammert J. 2016. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A 113:7852&#x2013;7857. doi:10.1073/pnas.1607931113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607931113</ArticleId><ArticleId IdType="pmc">PMC4948328</ArticleId><ArticleId IdType="pubmed">27354515</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanha PMS, Nascimento EJM, Braga C, Cordeiro MT, de Carvalho OV, de Mendon&#xe7;a LR, Azevedo EAN, Fran&#xe7;a RFO, Dhalia R, Marques ETA. 2017. Dengue virus (DENV)-specific antibodies enhance Brazilian Zika virus (ZIKV) infection. J Infect Dis 215:781&#x2013;785. doi:10.1093/infdis/jiw638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw638</ArticleId><ArticleId IdType="pmc">PMC5854042</ArticleId><ArticleId IdType="pubmed">28039355</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardina SV, Bunduc P, Tripathi S, Duehr J, Frere JJ, Brown JA, Nachbagauer R, Foster GA, Krysztof D, Tortorella D, Stramer SL, Garc&#xed;a-Sastre A, Krammer F, Lim JK. 2017. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 356:175&#x2013;180. doi:10.1126/science.aal4365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aal4365</ArticleId><ArticleId IdType="pmc">PMC5714274</ArticleId><ArticleId IdType="pubmed">28360135</ArticleId></ArticleIdList></Reference><Reference><Citation>Stettler K, Beltramello M, Espinosa DA, Graham V, Cassotta A, Bianchi S, Vanzetta F, Minola A, Jaconi S, Mele F, Foglierini M, Pedotti M, Simonelli L, Dowall S, Atkinson B, Percivalle E, Simmons CP, Varani L, Blum J, Baldanti F, Cameroni E, Hewson R, Harris E, Lanzavecchia A, Sallusto F, Corti D. 2016. Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection. Science 353:823&#x2013;826. doi:10.1126/science.aaf8505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf8505</ArticleId><ArticleId IdType="pubmed">27417494</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, O'Rourke EJ. 1977. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265:739&#x2013;741. doi:10.1038/265739a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/265739a0</ArticleId><ArticleId IdType="pubmed">404559</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmaseda A, Stettler K, Carrera RM, Collado D, Jin X, Zambrana JV, Jaconi S, Cameroni E, Saborio S, Rovida F, Percivalle E, Ijaz S, Dicks S, Ushiro-Lumb I, Barzon L, Siqueira P, Brown DWG, Baldanti F, Tedder R, Zambon M, Bispo de Filippis AM, Harris E, Corti D, 2017. Antibody-based assay discriminates Zika virus infection from other flaviviruses. Proc Natl Acad Sci U S A 114:8384&#x2013;8389. doi:10.1073/pnas.1704984114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704984114</ArticleId><ArticleId IdType="pmc">PMC5547631</ArticleId><ArticleId IdType="pubmed">28716913</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmaseda A, Zambrana JV, Collado D, Garc&#xed;a N, Sabor&#xed;o S, Elizondo D, Mercado JC, Gonzalez K, Cerpas C, Nu&#xf1;ez A, Corti D, Waggoner JJ, Kuan G, Burger-Calderon R, Harris E. 2018. Comparison of four serological methods and two reverse transcription-PCR assays for diagnosis and surveillance of Zika virus infection. J Clin Microbiol 56:e01785-17. doi:10.1128/JCM.01785-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01785-17</ArticleId><ArticleId IdType="pmc">PMC5824050</ArticleId><ArticleId IdType="pubmed">29305550</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai WY, Youn HH, Brites C, Tsai JJ, Tyson J, Pedroso C, Drexler JF, Stone M, Simmons G, Busch MP, Lanteri M, Stramer SL, Balmaseda A, Harris E, Wang WK. 2017. Distinguishing secondary dengue virus infection from Zika virus infection with previous dengue by combination of three simple serological tests. Clin Infect Dis 65:1829&#x2013;1836. doi:10.1093/cid/cix672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix672</ArticleId><ArticleId IdType="pmc">PMC5850648</ArticleId><ArticleId IdType="pubmed">29020159</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuan G, Gordon A, Avil&#xe9;s W, Ortega O, Hammond SN, Elizondo D, Nu&#xf1;ez A, Coloma J, Balmaseda A, Harris E. 2009. The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol 170:120&#x2013;129. doi:10.1093/aje/kwp092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwp092</ArticleId><ArticleId IdType="pmc">PMC2700880</ArticleId><ArticleId IdType="pubmed">19435864</ArticleId></ArticleIdList></Reference><Reference><Citation>Narvaez F, Gutierrez G, Perez MA, Elizondo D, Nu&#xf1;ez A, Balmaseda A, Harris E. 2011. Evaluation of the Traditional and revised WHO classifications of dengue disease severity. PLoS Negl Trop Dis 5:e1397. doi:10.1371/journal.pntd.0001397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001397</ArticleId><ArticleId IdType="pmc">PMC3210746</ArticleId><ArticleId IdType="pubmed">22087348</ArticleId></ArticleIdList></Reference><Reference><Citation>Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY. 2005. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med 353:451&#x2013;459. doi:10.1056/NEJMoa044333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa044333</ArticleId><ArticleId IdType="pubmed">16079368</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WK, Chen HL, Yang CF, Hsieh SC, Juan CC, Chang SM, Yu CC, Lin LH, Huang JH, King CC. 2006. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis 43:1023&#x2013;1030. doi:10.1086/507635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/507635</ArticleId><ArticleId IdType="pubmed">16983615</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai W-Y, Durbin A, Tsai J-J, Hsieh S-C, Whitehead S, Wang W-K. 2015. Complexity of neutralization antibodies against multiple dengue viral serotypes after heterotypic immunization and secondary infection revealed by in-depth analysis of cross-reactive antibodies. J Virol 89:7348&#x2013;7362. doi:10.1128/JVI.00273-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00273-15</ArticleId><ArticleId IdType="pmc">PMC4473561</ArticleId><ArticleId IdType="pubmed">25972550</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CY, Williams KL, Wu YC, Knight S, Balmaseda A, Harris E, Wang WK. 2013. Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases. PLoS Negl Trop Dis 7:e2451. doi:10.1371/journal.pntd.0002451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002451</ArticleId><ArticleId IdType="pmc">PMC3777924</ArticleId><ArticleId IdType="pubmed">24069496</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai JJ, Liu CK, Tsai WY, Liu LT, Tyson J, Tsai CY, Lin PC, Wang WK. 2018. Seroprevalence of dengue in two districts of Kaohsiung city after the largest dengue outbreak in Taiwan since World War II. PLoS Negl Trop Dis 12:e0006879. doi:10.1371/journal.pntd.0006879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0006879</ArticleId><ArticleId IdType="pmc">PMC6218099</ArticleId><ArticleId IdType="pubmed">30356316</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey A, Di Canzio J, Zurakowski D. 1998. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 221:35&#x2013;41. doi:10.1016/S0022-1759(98)00170-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-1759(98)00170-7</ArticleId><ArticleId IdType="pubmed">9894896</ArticleId></ArticleIdList></Reference><Reference><Citation>Paldanius M, Bloigu A, Leinonen M, Saikku P. 2003. Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one enzyme immunoassay kit. Clin Diagn Lab Immunol 10:8&#x2013;12. doi:10.1128/CDLI.10.1.8-12.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CDLI.10.1.8-12.2003</ArticleId><ArticleId IdType="pmc">PMC145278</ArticleId><ArticleId IdType="pubmed">12522032</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridhar S, Luedtke A, Langevin E, Zhu M, Bonaparte M, Machabert T, Savarino S, Zambrano B, Moureau A, Khromava A, Moodie Z, Westling T, Mascare&#xf1;as C, Frago C, Cort&#xe9;s M, Chansinghakul D, Noriega F, Bouckenooghe A, Chen J, Ng SP, Gilbert PB, Gurunathan S, DiazGranados CA. 2018. Effect of Dengue serostatus on dengue vaccine safety and efficacy. N Engl J Med 379:327&#x2013;340. doi:10.1056/NEJMoa1800820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1800820</ArticleId><ArticleId IdType="pubmed">29897841</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. 2017. Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age. Vaccine 35:6355&#x2013;6358. doi:10.1016/j.vaccine.2017.09.089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.09.089</ArticleId><ArticleId IdType="pubmed">29029938</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacobucci G. 2018. WHO recommends additional tests for Sanofi's dengue vaccine after safety concerns. BMJ 361:k1765. doi:10.1136/bmj.k1765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k1765</ArticleId><ArticleId IdType="pubmed">29678901</ArticleId></ArticleIdList></Reference><Reference><Citation>Normile D. 2017. Safety concerns derail dengue vaccination program. Science 358:1514&#x2013;1515. doi:10.1126/science.358.6370.1514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.358.6370.1514</ArticleId><ArticleId IdType="pubmed">29269451</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento EJM, George JK, Velasco M, Bonaparte MI, Zheng L, DiazGranados CA, Marques ETA, Huleatt JW. 2018. Development of an anti-dengue NS1 IgG ELISA to evaluate exposure to dengue virus. J Virol Methods 257:48&#x2013;57. doi:10.1016/j.jviromet.2018.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2018.03.007</ArticleId><ArticleId IdType="pubmed">29567514</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinhagen K, Probst C, Radzimski C, Schmidt-Chanasit J, Emmerich P, van Esbroeck M, Schinkel J, Grobusch MP, Goorhuis A, Warnecke JM, Lattwein E, Komorowski L, Deerberg A, Saschenbrecker S, St&#xf6;cker W, Schlumberger W. 2016. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016. Euro Surveill 21:30426. doi:10.2807/1560-7917.ES.2016.21.50.30426.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.50.30426</ArticleId><ArticleId IdType="pmc">PMC5291135</ArticleId><ArticleId IdType="pubmed">28006649</ArticleId></ArticleIdList></Reference><Reference><Citation>Lustig Y, Zelena H, Venturi G, Van Esbroeck M, Rothe C, Perret C, Koren R, Katz-Likvornik S, Mendelson E, Schwartz E. 2017. Sensitivity and kinetics of an NS1-based Zika virus enzyme-linked immunosorbent assay in Zika virus-infected travelers from Israel, the Czech Republic, Italy, Belgium, Germany, and Chile. J Clin Microbiol 55:1894&#x2013;1901. doi:10.1128/JCM.00346-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00346-17</ArticleId><ArticleId IdType="pmc">PMC5442546</ArticleId><ArticleId IdType="pubmed">28381608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquier C, Joguet G, Mengelle C, Chapuy-Regaud S, Pavili L, Prisant N, Izopet J, Bujan L, Mansuy JM. 2018. Kinetics of anti-ZIKV antibodies after Zika infection using two commercial enzyme-linked immunoassays. Diagn Microbiol Infect Dis 90:26&#x2013;30. doi:10.1016/j.diagmicrobio.2017.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2017.09.001</ArticleId><ArticleId IdType="pubmed">29107414</ArticleId></ArticleIdList></Reference><Reference><Citation>Safronetz D, Sloan A, Stein DR, Mendoza E, Barairo N, Ranadheera C, Scharikow L, Holloway K, Robinson A, Traykova-Andonova M, Makowski K, Dimitrova K, Giles E, Hiebert J, Mogk R, Beddome S, Drebot M. 2017. Evaluation of 5 commercially available Zika virus immunoassays. Emerg Infect Dis 23:1577&#x2013;1580. doi:10.3201/eid2309.162043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2309.162043</ArticleId><ArticleId IdType="pmc">PMC5572859</ArticleId><ArticleId IdType="pubmed">28665268</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins MH, McGowan E, Jadi R, Young E, Lopez CA, Baric RS, Lazear HM, de Silva AM. 2017. Lack of durable cross-neutralizing antibodies against Zika virus from dengue virus infection. Emerg Infect Dis 23:773&#x2013;781. doi:10.3201/eid2305.161630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2305.161630</ArticleId><ArticleId IdType="pmc">PMC5403059</ArticleId><ArticleId IdType="pubmed">28418292</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya M, Collins M, Dejnirattisai W, Katzelnick LC, Puerta-Guardo H, Jadi R, Schildhauer S, Supasa P, Vasanawathana S, Malasit P, Mongkolsapaya J, de Silva AD, Tissera H, Balmaseda A, Screaton G, de Silva AM, Harris E. 2018. Longitudinal analysis of antibody cross-neutralization following Zika virus and dengue virus infection in Asia and the Americas. J Infect Dis 218:536&#x2013;545. doi:10.1093/infdis/jiy164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiy164</ArticleId><ArticleId IdType="pmc">PMC6047418</ArticleId><ArticleId IdType="pubmed">29618091</ArticleId></ArticleIdList></Reference><Reference><Citation>Honein MA, Dawson AL, Petersen EE, Jones AM, Lee EH, Yazdy MM, Ahmad N, Macdonald J, Evert N, Bingham A, Ellington SR, Shapiro-Mendoza CK, Oduyebo T, Fine AD, Brown CM, Sommer JN, Gupta J, Cavicchia P, Slavinski S, White JL, Owen SM, Petersen LR, Boyle C, Meaney-Delman D, Jamieson DJ, U.S. Zika Pregnancy Registry Collaboration. 2017. Birth defects among fetuses and infants of U.S. women with evidence of possible Zika virus infection during pregnancy. JAMA 317:59&#x2013;68. doi:10.1001/jama.2016.19006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.19006</ArticleId><ArticleId IdType="pubmed">27960197</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore CA, Staples JE, Dobyns WB, Pessoa A, Ventura CV, Fonseca EB, Ribeiro EM, Ventura LO, Neto NN, Arena JF, Rasmussen SA. 2017. Characterizing the pattern of anomalies in congenital Zika syndrome for pediatric clinicians. JAMA Pediatr 171:288&#x2013;295. doi:10.1001/jamapediatrics.2016.3982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2016.3982</ArticleId><ArticleId IdType="pmc">PMC5561417</ArticleId><ArticleId IdType="pubmed">27812690</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Linden V, Pessoa A, Dobyns W, Barkovich AJ, J&#xfa;nior HV, Filho EL, Ribeiro EM, Leal MC, Coimbra PP, Arag&#xe3;o MF, Ver&#xe7;osa I, Ventura C, Ramos RC, Cruz DD, Cordeiro MT, Mota VM, Dott M, Hillard C, Moore CA. 2016. Description of 13 infants born during October 2015&#x2013;January 2016 with congenital Zika virus infection without microcephaly at birth&#x2013;Brazil. MMWR Morb Mortal Wkly Rep 65:1343&#x2013;1348. doi:10.15585/mmwr.mm6547e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6547e2</ArticleId><ArticleId IdType="pubmed">27906905</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Jordan JL. 2017. Diagnosis of Zika Virus infections: challenges and opportunities. J Infect Dis 216:S951&#x2013;S956. doi:10.1093/infdis/jix502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix502</ArticleId><ArticleId IdType="pmc">PMC5853979</ArticleId><ArticleId IdType="pubmed">29267922</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons G, Stone M, Busch MP. 2018. Arbovirus diagnostics: from bad to worse due to expanding dengue virus vaccination and Zika virus epidemics. Clin Infect Dis 66:1181&#x2013;1183. doi:10.1093/cid/cix972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix972</ArticleId><ArticleId IdType="pmc">PMC6248677</ArticleId><ArticleId IdType="pubmed">29301009</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>